✦ LIBER ✦

Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial

✍ Scribed by Kamat, Ashish M.; Dickstein, Rian J.; Messetti, Fabrizio; Anderson, Roosevelt; Pretzsch, Shanna M.; Gonzalez, Graciela Noguera; Katz, Ruth L.; Khanna, Abha; Zaidi, Tanweer; Wu, Xifeng; Grossman, H. Barton; Dinney, Colin P.

Book ID: 118484142
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 606 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.10.144

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Utility of Fluorescent in situ

Clinical Utility of Fluorescent in situ Hybridization for the Surveillance of Bladder Cancer Patients Treated with Bacillus Calmette-Guérin Therapy

✍ Lourdes Mengual; Mercedes Marín-Aguilera; María José Ribal; Moisès Burset; Humbe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 197 KB

The prognostic value of cytology and flu

The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy

✍ Spasenija Savic; Inti Zlobec; George N. Thalmann; Daniel Engeler; Martina Schmau 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 169 KB

## Abstract Molecular markers reliably predicting failure or success of Bacillus Calmette‐Guérin (BCG) in the treatment of nonmuscle‐invasive urothelial bladder cancer (NMIBC) are lacking. The aim of our study was to evaluate the value of cytology and chromosomal aberrations detected by fluorescenc

Possible factors affecting response to i

Possible factors affecting response to intravesical bacillus Calmette-Guérin (Tokyo 172 Strain) therapy for carcinoma in situ of the bladder: A multivariate analysis

✍ M. Takashi; S. Katsuno; H. Yuba; S. Ohshima; K. Wakai; Y. Ohno 📂 Article 📅 1998 🏛 Springer Netherlands 🌐 English ⚖ 541 KB

Paclitaxel-Hyaluronic Acid for Intravesi

Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guérin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study

✍ Bassi, P.F.; Volpe, A.; D'Agostino, D.; Palermo, G.; Renier, D.; Franchini, S.; 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 84 KB

Modulating the immune response to Bacill

Modulating the immune response to Bacillus Calmette-Guérin (BCG): a novel way to increase the immunotherapeutic effect of BCG for treatment of bladder cancer?

✍ Sapre, Nikhil; Corcoran, Niall M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Intravesical bacillus Calmette-Guérin is

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials

✍ M.D. Shelley; T.J. Wilt; J. Court; B. Coles; H. Kynaston; M.D. Mason 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB